In this unblinded trial, patients were randomly assigned either to un- dergo a 24-hour capping trial plus intermittent high-flow oxygen therapy (control group) or to receive continuous high-flow oxygen therapy with frequency of suc- tioning being the indicator of readiness for decannulation (intervention group).